Wavre, Belgium

Philippe Van Den Bosch De Aguilar

This inventor holds 1 USPTO granted patent. Top assignee: Universitè Catholique De Louvain. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philippe Van Den Bosch De Aguilar. Retrieved from https://idiyas.com/inventor/philippe-van-den-bosch-de-aguilar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 107(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Philippe Van Den Bosch De Aguilar: Innovator in Biomaterials

Introduction

Philippe Van Den Bosch De Aguilar is a notable inventor based in Wavre, Belgium. He has made significant contributions to the field of biomaterials, showcasing his expertise through his innovative work.

Latest Patents

Philippe holds a patent for a biomaterial and the method for obtaining it. This invention reflects his commitment to advancing materials science and its applications in various industries.

Career Highlights

Philippe is affiliated with Université Catholique de Louvain, where he continues to engage in research and development. His work at this esteemed institution has allowed him to explore new frontiers in biomaterials.

Collaborations

He has collaborated with esteemed colleagues such as Paul Rouxhet and Eric Detrait, contributing to a dynamic research environment that fosters innovation.

Conclusion

Philippe Van Den Bosch De Aguilar's contributions to biomaterials exemplify the impact of dedicated research and collaboration in advancing technology. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…